Informations générales (source: ClinicalTrials.gov)
Non-invasive Prenatal Testing of Placental Chromosomal Abnormalities in Fetus With Intrauterine Growth Restriction (DPNI-RCIU)
Observational
University Hospital, Bordeaux (Voir sur ClinicalTrials)
octobre 2021
octobre 2024
29 juin 2024
The objective of this project is the non-invasive prenatal detection of placenta-limited
aneuploidies, in patients whose fetuses have a intrauterine growth restriction below 3rd
percentile, in parallel with an amniocentesis.
This study will allow the chromosomal study of the placenta in pregnant women whose
genetic prenatal diagnosis, made by amniocentesis, does not allow exploring the placental
causes of fetal RCIU.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre Hospitalier Universitaire de Bordeaux - Bordeaux - France | Caroline THAMBO | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CHU Toulouse - 31059 - Toulouse - France | Christophe VAYSSIERE, PROF | Contact (sur clinicalTrials) | |||
| Hôpital Antoine Béclère - 92140 - Clamart - France | Alexandre VIVANTI, MD | Contact (sur clinicalTrials) | |||
Critères
Femme
Inclusion Criteria:
- over 18 years old,
- treated in the DDIANE fetal medicine centre at the Bordeaux University Hospital,
- having a fetus with IUGR diagnosis below the 3rd percentile (after reference medical
ultrasound),
- from 16 weeks of amenorrhea or more,
- accepting an Invasive Prenatal Diagnosis by amniocentesis with array comparative
genomic hybridization
- over 18 years old,
- treated in the DDIANE fetal medicine centre at the Bordeaux University Hospital,
- having a fetus with IUGR diagnosis below the 3rd percentile (after reference medical
ultrasound),
- from 16 weeks of amenorrhea or more,
- accepting an Invasive Prenatal Diagnosis by amniocentesis with array comparative
genomic hybridization
Childbearing women who:
- do not accept a non-invasive prenatal diagnosis (amniocentesis)
- have a fetus with non-isolated IUGR (associated with other ultrasound signs)
- do not consent to participate in the research protocol